Overexpression of FASN significantly decreased the total and lipid ROS levels, down-regulated 4-HNE expression, yet up-regulated the GPX4 expression in ADM-treated DLBCL cells, SU-DHL-2. Here, FASN is linked to diffuse large B-cell lymphoma.